Imaging Surrogates of Disease Activity in Neuromyelitis Optica Allow Distinction from Multiple Sclerosis

Por um escritor misterioso
Last updated 16 junho 2024
Imaging Surrogates of Disease Activity in Neuromyelitis Optica Allow  Distinction from Multiple Sclerosis
Imaging Surrogates of Disease Activity in Neuromyelitis Optica Allow  Distinction from Multiple Sclerosis
Multiple sclerosis - The Lancet
Imaging Surrogates of Disease Activity in Neuromyelitis Optica Allow  Distinction from Multiple Sclerosis
Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management
Imaging Surrogates of Disease Activity in Neuromyelitis Optica Allow  Distinction from Multiple Sclerosis
KJR :: Korean Journal of Radiology
Imaging Surrogates of Disease Activity in Neuromyelitis Optica Allow  Distinction from Multiple Sclerosis
Neuromyelitis Optica Spectrum Disorders: Spectrum of MR Imaging Findings and Their Differential Diagnosis
Imaging Surrogates of Disease Activity in Neuromyelitis Optica Allow  Distinction from Multiple Sclerosis
Differentiating Multiple Sclerosis From AQP4-Neuromyelitis Optica Spectrum Disorder and MOG-Antibody Disease With Imaging
Imaging Surrogates of Disease Activity in Neuromyelitis Optica Allow  Distinction from Multiple Sclerosis
Differentiating Multiple Sclerosis From AQP4-Neuromyelitis Optica Spectrum Disorder and MOG-Antibody Disease With Imaging
Imaging Surrogates of Disease Activity in Neuromyelitis Optica Allow  Distinction from Multiple Sclerosis
IJMS, Free Full-Text
Imaging Surrogates of Disease Activity in Neuromyelitis Optica Allow  Distinction from Multiple Sclerosis
Frontiers Clinical Characteristics and Outcomes of Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder With Brainstem Lesions as Heralding Prodrome
Imaging Surrogates of Disease Activity in Neuromyelitis Optica Allow  Distinction from Multiple Sclerosis
Frontiers A review on multiple sclerosis prognostic findings from imaging, inflammation, and mental health studies
Imaging Surrogates of Disease Activity in Neuromyelitis Optica Allow  Distinction from Multiple Sclerosis
Frontiers Serum and Cerebrospinal Fluid Biomarkers in Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Associated Disease

© 2014-2024 rahh.de. All rights reserved.